Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.86 |
| ▸ | TSHR | P16473 | 1/20 | 0.86 |
| ▸ | HPGD | P15428 | 2/20 | 0.77 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | HSD11B1 | P28845 | 9/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | HSD11B2 | P80365 | 2/20 | 0.57 |
| ▸ | GRM5 | P41594 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3703105 | 0.97 | ALDH1A1 (0.81) | ALDH1A1TSHRHPGDLMNAHSD11B1 | |
| SCHEMBL2386976 | 0.95 | ALDH1A1 (0.86) | ALDH1A1TSHRHPGDLMNAHSD11B1 | |
| SCHEMBL60471 | 0.95 | ALDH1A1 (0.86) | ALDH1A1TSHRHPGDLMNAHSD11B1 | |
| SCHEMBL1826063 | 0.95 | ALDH1A1 (0.86) | ALDH1A1TSHRHPGDLMNAHSD11B1 | |
| SCHEMBL4057588 | 0.95 | ALDH1A1 (0.86) | ALDH1A1TSHRHPGDLMNAHSD11B1 | |
| SCHEMBL3695372 | 0.95 | ALDH1A1 (0.86) | ALDH1A1TSHRHPGDLMNAHSD11B1 | |
| SCHEMBL10559542 | 0.92 | ALDH1A1 (1.00) | ALDH1A1TSHRHPGDLMNAHSD11B1 | |
| SCHEMBL3708786 | 0.92 | ALDH1A1 (0.73) | ALDH1A1TSHRHPGDLMNAHSD11B1 | |
| SCHEMBL3703489 | 0.92 | ALDH1A1 (0.81) | ALDH1A1TSHRHPGDLMNAHSD11B1 | |
| SCHEMBL7131881 | 0.92 | ALDH1A1 (1.00) | ALDH1A1TSHRHPGDLMNAHSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119955091-A | Polymer, positive-type negative-type photosensitive resin composition, pattern forming method, cured film forming method, interlayer insulating film, surface protective film, and electronic component | 信越化学工业株式会社 | 2025-05-09 | — | — | CN | disclosed |
| CN-118210199-A | Photosensitive resin composition, cured film pattern, and method for producing same | 奇美实业股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| US-20230312605-A1 | PYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF | TENARX, INC. | 2023-10-05 | — | — | US | disclosed |
| WO-2023064366-A1 | PYRROLO[2,1-F][1,2,4]TRIAZINES DERIVATIVES AS INHIBITORS OF DYRK1A | BIOSPLICE THERAPEUTICS, INC. (US) | 2023-04-20 | — | — | WO | disclosed |
| CN-115113484-A | Positive photosensitive resin composition, positive photosensitive dry film, method for producing the same, and method for forming pattern | 信越化学工业株式会社 | 2022-09-27 | — | — | CN | disclosed |
| CN-107561863-B | Positive photosensitive resin composition and application thereof | 奇美实业股份有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-114253069-A | Photosensitive resin composition, pattern forming method, cured film forming method, interlayer insulating film, and surface protective film | 信越化学工业株式会社 | 2022-03-29 | — | — | CN | disclosed |
| WO-2019116325-A1 | TRICYCLIC COMPOUNDS AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS | RICHTER GEDEON NYRT. (HU) | 2019-06-20 | — | — | WO | disclosed |
| US-10162260-B2 | Photosensitive resin composition, protective film, and liquid crystal display element | CHI MEI CORPORATION (TW) | 2018-12-25 | — | — | US | disclosed |
| CN-104860924-B | Melanocortin-4 receptor modulators prepare their method and its purposes in human medicine and cosmetics | 盖尔德马研究及发展公司 | 2018-10-09 | — | — | CN | disclosed |
| CN-104860924-A | Melanocortin receptor modulators, process for preparing same and use there in human medicine and cosmetics | GALDERMA RES & DEV | 2015-08-26 | — | — | CN | disclosed |
| CN-102203082-B | Melanocortin receptor modulators, processes for preparing them and their use in human medicine and cosmetics | GALDERMA RES & DEV | 2015-04-29 | — | — | CN | disclosed |
| CN-104375381-A | Photosensitive polysiloxane composition, film formed by photosensitive polysiloxane composition and device comprising film | CHI MEI CORP | 2015-02-25 | — | — | CN | disclosed |
| US-20150050596-A1 | PHOTOSENSITIVE POLYSILOXANE COMPOSITION AND USES THEREOF | CHI MEI CORPORATION (TW) | 2015-02-19 | — | — | US | disclosed |
| US-8877968-B2 | Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2014-11-04 | — | — | US | disclosed |
| EP-2352728-B1 | MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS | GALDERMA RES & DEV (FR) | 2014-05-21 | — | — | EP | disclosed |
| US-20110275657-A1 | MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THERE IN HUMAN MEDICINE AND COSMETICS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2011-11-10 | — | — | US | disclosed |
| CN-102203082-A | Melanocortin receptor modulators, processes for preparing them and their use in human medicine and cosmetics | GALDERMA RES & DEV | 2011-09-28 | — | — | CN | disclosed |
| EP-2352728-A1 | MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS | Galderma Research & Development (FR) | 2011-08-10 | — | — | EP | disclosed |
| WO-2010052255-A1 | MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2010-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312605-A1 | PYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF | DYRK1A, DYRK2, DYRK1B | ALDH1A1 3166/4885TSHR 1054/4885HPGD 3630/4885 |
| US-20110275657-A1 | MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THERE IN HUMAN MEDICINE AND COSMETICS | MC1R, MC5R, MC3R | ALDH1A1 2022/4885TSHR 30/4885HPGD 921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.